University Hospital Bispebjerg and Frederiksberg clinical trials
University Hospital Bispebjerg and Frederiksberg is the lead sponsor of 16 current clinical trials in our Denmark and Brazil registers. 13 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Lamotrigine and Lithium Carbonate. The most-studied condition is Atrial Fibrillation.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by University Hospital Bispebjerg and Frederiksberg
16 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Brazilian Heart Insufficiency With Telemedicine
NCT04466852 · ClinicalTrials.gov ↗ · Heart Failure
|
Not applicable | Recruiting | 2020-08 | Brazil |
|
The Advance Project - Advancing Sleep Timing to Improve Depression
NCT06097221 · Depression
|
Not applicable | Recruiting | 2024-04 | Denmark |
|
Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate
NCT06405750 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Stroke
|
Not applicable | Recruiting | 2024-08 | Denmark |
|
Oral Health and Adverse Pregnancy Complications
NCT06110143 · ClinicalTrials.gov ↗ · Periodontal Diseases, Pregnancy Complications, Pregnancy Preterm
|
Not applicable | Recruiting | 2021-11 | Denmark |
|
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
NCT07189260 · ClinicalTrials.gov ↗ · Hip Fractures (ICD-10 72.01-72.2)
|
Not applicable | Recruiting | 2024-02 | Denmark |
|
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
NCT06184581 · ClinicalTrials.gov ↗ · Bipolar II Disorder
Drugs: Lamotrigine, Lithium Carbonate |
Phase 4 | Recruiting | 2024-05 | Denmark |
|
Weighted Blankets for Sleep Disturbance Among Children With ADHD
NCT06194162 · ClinicalTrials.gov ↗ · Attention-deficit Hyperactivity, Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders
|
Not applicable | Recruiting | 2024-01 | Denmark |
|
The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure
NCT06176131 · ClinicalTrials.gov ↗ · Heart Failure,Congestive, Atrial Fibrillation
|
Observational | Recruiting | 2024-01 | Denmark |
|
Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons
NCT06142747 · ClinicalTrials.gov ↗ · Tendinopathy
|
Observational | Recruiting | 2024-02 | Denmark |
|
PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder
NCT06563466 · ClinicalTrials.gov ↗ · Borderline Personality Disorder, Relatives
|
Not applicable | Recruiting | 2024-09 | Denmark |
|
Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment
NCT07807228 · ClinicalTrials.gov ↗ · Atopic Dermatitis
|
Observational | Recruiting | 2025-06 | Denmark |
|
Retail-Grade Weighted Blanket Effectiveness on ADHD-related Sleep Disturbances (BEAD)
NCT07588659 · ADHD - Attention Deficit Disorder With Hyperactivity
|
Not applicable | Recruiting | 2026-08 | Denmark |
|
Medicines in Breast Milk and Estimated Infant Exposure
NCT07346716 · ClinicalTrials.gov ↗ · Breastfeeding, Medication Safety, Lactation
|
Observational | Recruiting | 2024-12 | Denmark |
|
Comparison of Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between Patients with Type 2 Diabetes and Healthy Age Matched Controls.
NCT06628297 · ClinicalTrials.gov ↗ · Microvascular Disease, Microvascular Complications, Dementia
|
Observational | Not yet open | 2024-11 | Denmark |
|
Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion
NCT06624267 · ClinicalTrials.gov ↗ · Microvascular Disease, Microvascular Complications, Diabetes Mellitus Type 2
|
Observational | Not yet open | 2024-11 | Denmark |
|
STEPS: A Virtual Reality-based Intervention for Adults With Autism.
NCT06438536 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder
|
Not applicable | Active, closed | 2024-05 | Denmark |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in University Hospital Bispebjerg and Frederiksberg trials
2 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in University Hospital Bispebjerg and Frederiksberg trials
30 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Denmark | 15 | 12 |
| Clinical trials in Brazil | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Atrial Fibrillation
Sponsors with the most current trials registered for this condition.
Questions about University Hospital Bispebjerg and Frederiksberg trials
How many clinical trials does University Hospital Bispebjerg and Frederiksberg sponsor?
University Hospital Bispebjerg and Frederiksberg is the lead sponsor of 16 current trials on ClinicalTrials.gov in our Denmark and Brazil registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.
Are University Hospital Bispebjerg and Frederiksberg trials recruiting?
Yes. 13 of its 16 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is University Hospital Bispebjerg and Frederiksberg testing?
Its current trials name 2 drugs and biologicals as interventions. The most frequent are Lamotrigine (1) and Lithium Carbonate (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.